These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 17525722)
1. Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells. Smits EL; Ponsaerts P; Van de Velde AL; Van Driessche A; Cools N; Lenjou M; Nijs G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF Leukemia; 2007 Aug; 21(8):1691-9. PubMed ID: 17525722 [TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells. Lion E; Smits EL; Berneman ZN; Van Tendeloo VF Leuk Res; 2009 Apr; 33(4):539-46. PubMed ID: 18845337 [TBL] [Abstract][Full Text] [Related]
3. Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons. Kunzmann V; Kretzschmar E; Herrmann T; Wilhelm M Immunology; 2004 Jul; 112(3):369-77. PubMed ID: 15196204 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells. Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495 [TBL] [Abstract][Full Text] [Related]
5. AML-loaded DC generate Th1-type cellular immune responses in vitro. Xing D; Decker WK; Li S; Robinson SN; Yang H; Segal H; O'Connor S; Yao X; Komanduri KV; McMannis JD; Jones RB; de Lima M; Champlin RE; Shpall EJ Cytotherapy; 2006; 8(2):95-104. PubMed ID: 16698683 [TBL] [Abstract][Full Text] [Related]
6. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Wörnle M; Schmid H; Banas B; Merkle M; Henger A; Roeder M; Blattner S; Bock E; Kretzler M; Gröne HJ; Schlöndorff D Am J Pathol; 2006 Feb; 168(2):370-85. PubMed ID: 16436653 [TBL] [Abstract][Full Text] [Related]
7. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant. Hafner AM; Corthésy B; Merkle HP Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781 [TBL] [Abstract][Full Text] [Related]
8. Two-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacity. Kim HJ; Kim HO; Lee K; Baek EJ; Kim HS Vaccine; 2010 Apr; 28(16):2877-86. PubMed ID: 20156531 [TBL] [Abstract][Full Text] [Related]
9. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. Krumbiegel D; Zepp F; Meyer CU Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769 [TBL] [Abstract][Full Text] [Related]
11. Neuropeptide signaling activates dendritic cell-mediated type 1 immune responses through neurokinin-2 receptor. Kitamura H; Kobayashi M; Wakita D; Nishimura T J Immunol; 2012 May; 188(9):4200-8. PubMed ID: 22474018 [TBL] [Abstract][Full Text] [Related]
12. Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA. Michiels A; Breckpot K; Corthals J; Tuyaerts S; Bonehill A; Heirman C; Thielemans K; Aerts JL Gene Ther; 2006 Jul; 13(13):1027-36. PubMed ID: 16511519 [TBL] [Abstract][Full Text] [Related]
13. Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075. Spranger S; Javorovic M; Bürdek M; Wilde S; Mosetter B; Tippmer S; Bigalke I; Geiger C; Schendel DJ; Frankenberger B J Immunol; 2010 Jul; 185(1):738-47. PubMed ID: 20511554 [TBL] [Abstract][Full Text] [Related]
14. Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia. Mohty M; Isnardon D; Blaise D; Mozziconacci MJ; Lafage-Pochitaloff M; Brière F; Gastaut JA; Olive D; Gaugler B Leukemia; 2002 Nov; 16(11):2267-74. PubMed ID: 12399972 [TBL] [Abstract][Full Text] [Related]
15. Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting. Houtenbos I; Westers TM; Dijkhuis A; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA Clin Cancer Res; 2007 Jan; 13(1):307-15. PubMed ID: 17170077 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Ebihara T; Shingai M; Matsumoto M; Wakita T; Seya T Hepatology; 2008 Jul; 48(1):48-58. PubMed ID: 18537195 [TBL] [Abstract][Full Text] [Related]
17. Intracellular delivery of major histocompatibility complex class I-binding epitopes: dendritic cells loaded and matured with cationic peptide/poly(I:C) complexes efficiently activate T cells. Haenssle HA; Riedl P; Buhl T; Schardt A; Rosenberger A; Schön MP; Schirmbeck R Exp Dermatol; 2010 Jan; 19(1):19-28. PubMed ID: 19758325 [TBL] [Abstract][Full Text] [Related]
18. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia. Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411 [TBL] [Abstract][Full Text] [Related]
19. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7. Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792 [TBL] [Abstract][Full Text] [Related]